Natural killer cells efficiently target multiple myeloma clonogenic tumor cells

The multiple myeloma (MM) landscape has changed in the last few years, but most patients eventually relapse because current treatment modalities do not target clonogenic stem cells, which are drug-resistant and can self-renew. We hypothesized that side population (SP) cells represent myeloma clonoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Leivas, Alejandra, Risueño, Ruth M., Guzmán, Alma, Sánchez-Vega, Laura, Pérez, Manuel, Megías, Diego, Fernández, Lucía, Alonso, Rafael, Pérez-Martínez, Antonio, Rapado, Inmaculada, Martínez-López, Joaquín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423695/
https://www.ncbi.nlm.nih.gov/pubmed/33693963
http://dx.doi.org/10.1007/s00262-021-02901-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423695/
https://www.ncbi.nlm.nih.gov/pubmed/33693963
http://dx.doi.org/10.1007/s00262-021-02901-y

Ejemplares similares